{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:13:00Z","timestamp":1761059580215},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T00:00:00Z","timestamp":1376870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072458","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T21:08:12Z","timestamp":1376946492000},"page":"e72458","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identification of Novel Autoantibodies for Detection of Malignant Mesothelioma"],"prefix":"10.1371","volume":"8","author":[{"given":"Xufei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weike","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemp H.","family":"Kernstine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-5002(02)00449-X","article-title":"Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases","volume":"39","author":"M Neri","year":"2003","journal-title":"Lung Cancer"},{"key":"ref2","first-page":"213","article-title":"[Mesothelioma registry of the Liguria region. Incidence and occupational etiology in a high risk area]","volume":"24","author":"V Gennaro","year":"2000","journal-title":"Epidemiol Prev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/oem.52.6.362","article-title":"Pleural malignant mesothelioma and non-occupational exposure to asbestos in Casale Monferrato, Italy","volume":"52","author":"C Magnani","year":"1995","journal-title":"Occup Environ Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-07-0607","article-title":"Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study","volume":"17","author":"M Amati","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"BW Robinson","year":"2005","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0025-6196(11)60848-3","article-title":"Recent advances in the diagnosis and management of malignant pleural effusions","volume":"83","author":"JE Heffner","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/107327480601300402","article-title":"Malignant pleural mesothelioma: a comprehensive review","volume":"13","author":"R Ismail-Khan","year":"2006","journal-title":"Cancer Control"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MCP.0b013e32832b98eb","article-title":"Serum and pleural fluid biomarkers for mesothelioma","volume":"15","author":"J Creaney","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.lungcan.2004.04.010","article-title":"Epidemiology of malignant mesothelioma in Australia","volume":"45","author":"AW Musk","year":"2004","journal-title":"Lung Cancer"},{"key":"ref10","first-page":"151","article-title":"Asbestos exposure, lung cancer and asbestosis","volume":"55","author":"CG Billings","year":"2000","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.trsl.2009.01.004","article-title":"Asbestos-induced lung diseases: an update","volume":"153","author":"DW Kamp","year":"2009","journal-title":"Transl Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1054\/bjoc.2000.1529","article-title":"p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression","volume":"84","author":"J Creaney","year":"2001","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s002680020021","article-title":"Treatment of malignant mesothelioma","volume":"25","author":"MT Jaklitsch","year":"2001","journal-title":"World J Surg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.117.1.79","article-title":"Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions","volume":"117","author":"JE Heffner","year":"2000","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e46091","DOI":"10.1371\/journal.pone.0046091","article-title":"Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool","volume":"7","author":"RM Ostroff","year":"2012","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e26515","DOI":"10.1371\/journal.pone.0026515","article-title":"Auto-antibodies to beta-F1-ATPase and vimentin in malignant mesothelioma","volume":"6","author":"J Creaney","year":"2011","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1010-7940(02)00273-7","article-title":"The management of malignant pleural mesothelioma; single centre experience in 10 years","volume":"22","author":"T Aziz","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref18","first-page":"70","article-title":"Mesothelioma: a review","volume":"12","author":"FE Mott","year":"2012","journal-title":"Ochsner J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5","article-title":"Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging","volume":"72","author":"C Boutin","year":"1993","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2011.104","article-title":"Markers for the non-invasive diagnosis of mesothelioma: a systematic review","volume":"104","author":"S van der Bij","year":"2011","journal-title":"Br J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1373\/clinchem.2006.079327","article-title":"MESOMARK: a potential test for malignant pleural mesothelioma","volume":"53","author":"HL Beyer","year":"2007","journal-title":"Clin Chem"},{"key":"ref22","first-page":"464","article-title":"[Diagnostic biomarkers of malignant pleural mesothelioma]","volume":"133","author":"JA Rodriguez Portal","year":"2009","journal-title":"Med Clin (Barc)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2008.02.012","article-title":"Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin","volume":"62","author":"K Iwahori","year":"2008","journal-title":"Lung Cancer"},{"key":"ref24","first-page":"4249","article-title":"CYFRA 21-1 serum analysis in patients with esophageal cancer","volume":"6","author":"JG Brockmann","year":"2000","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/0008-5472.CAN-06-3369","article-title":"Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas","volume":"67","author":"T Yamabuki","year":"2007","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","article-title":"American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer","volume":"25","author":"L Harris","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/1078-0432.CCR-03-0160","article-title":"Loss of heterozygosity and internal tandem duplication mutations of the CBP gene are frequent events in human esophageal squamous cell carcinoma","volume":"10","author":"CK So","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1172\/JCI14451","article-title":"Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis","volume":"108","author":"EM Tan","year":"2001","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1165\/ajrcmb.22.5.3930","article-title":"Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities","volume":"22","author":"C Robinson","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ijc.2910520609","article-title":"Establishment of a murine model of malignant mesothelioma","volume":"52","author":"MR Davis","year":"1992","journal-title":"Int J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01534421","article-title":"Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model","volume":"39","author":"H Bielefeldt-Ohmann","year":"1994","journal-title":"Cancer Immunol Immunother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2407-8-236","article-title":"National Mesothelioma Virtual Bank: a standard based biospecimen and clinical data resource to enhance translational research","volume":"8","author":"W Amin","year":"2008","journal-title":"BMC Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.200505-830OC","article-title":"Using protein microarray as a diagnostic assay for non-small cell lung cancer","volume":"172","author":"L Zhong","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-0381-4-13","article-title":"Preprocessing differential methylation hybridization microarray data","volume":"4","author":"S Sun","year":"2011","journal-title":"BioData Min"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Hua J, Balagurunathan Y, Chen Y, Lowey J, Bittner ML, <etal>et al<\/etal>.. (2006) Normalization benefits microarray-based classification. EURASIP J Bioinform Syst Biol: 43056.","DOI":"10.1155\/BSB\/2006\/43056"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00253-006-0536-x","article-title":"Comparison of different approaches for comparative genetic analysis using microarray hybridization","volume":"72","author":"C Pin","year":"2006","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/bioinformatics\/18.2.325","article-title":"Tclass: tumor classification system based on gene expression profile","volume":"18","author":"L Wuju","year":"2002","journal-title":"Bioinformatics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1074\/mcp.M500055-MCP200","article-title":"An approach to studying lung cancer-related proteins in human blood","volume":"4","author":"T Xiao","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1186\/bcr1295","article-title":"How many genes are needed for early detection of breast cancer, based on gene expression patterns in peripheral blood cells?","volume":"7","author":"W Li","year":"2005","journal-title":"Breast Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bbrc.2008.05.046","article-title":"Construction of two mathematical models for prediction of bacterial sRNA targets","volume":"372","author":"Y Zhao","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20040116","article-title":"Functional analysis of the CXXC motif using phage antibodies that cross-react with protein disulphide-isomerase family proteins","volume":"382","author":"T Kimura","year":"2004","journal-title":"Biochem J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.radonc.2009.05.019","article-title":"Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics","volume":"92","author":"BS Sorensen","year":"2009","journal-title":"Radiother Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1210\/jc.2003-030222","article-title":"A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells","volume":"88","author":"X Zhang","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Ying L, Huang Y, Chen H, Wang Y, Xia L, <etal>et al<\/etal>.. (2013) Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst.","DOI":"10.1039\/c2mb25386k"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/dna.2005.24.777","article-title":"Serologically defined colon cancer antigen 3 is necessary for the presentation of TNF receptor 1 on cell surface","volume":"24","author":"N Neznanov","year":"2005","journal-title":"DNA Cell Biol"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Hagemann N, Ackermann N, Christmann J, Brier S, Yu F, <etal>et al<\/etal>.. (2012) The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesis. Oncogene.","DOI":"10.1038\/onc.2012.485"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e318213d51b","article-title":"The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms","volume":"40","author":"X Li","year":"2011","journal-title":"Pancreas"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1755-8794-4-49","article-title":"Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival","volume":"4","author":"NV Serao","year":"2011","journal-title":"BMC Med Genomics"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11033-012-1944-x","article-title":"Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell","volume":"40","author":"B Pan","year":"2013","journal-title":"Mol Biol Rep"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Ledet EM, Hu X, Sartor O, Rayford W, Li M, <etal>et al<\/etal>.. (2012) Characterization of germline copy number variation in high-risk African American families with prostate cancer. Prostate.","DOI":"10.1002\/pros.22602"},{"key":"ref51","first-page":"507","article-title":"Gene expression profiling in women with breast cancer in a Saudi population","volume":"29","author":"SM Bin Amer","year":"2008","journal-title":"Saudi Med J"},{"key":"ref52","first-page":"247","article-title":"Identification by means of cDNA microarray analyses of gene expression modifications in squamous non-small cell lung cancers as compared to normal bronchial epithelial tissue","volume":"26","author":"M Remmelink","year":"2005","journal-title":"Int J Oncol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/thx.2007.083592","article-title":"Autoantibodies in lung cancer: possibilities for early detection and subsequent cure","volume":"63","author":"CJ Chapman","year":"2008","journal-title":"Thorax"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-03-3070","article-title":"NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors","volume":"64","author":"Y Sugita","year":"2004","journal-title":"Cancer Res"},{"key":"ref55","first-page":"4","article-title":"Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression","volume":"1","author":"MJ Scanlan","year":"2001","journal-title":"Cancer Immun"},{"key":"ref56","first-page":"137","article-title":"Tumor associated antigen recognition by autologous serum in patients with breast cancer","volume":"15","author":"F Qian","year":"2005","journal-title":"Int J Mol Med"},{"key":"ref57","first-page":"2055","article-title":"Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library","volume":"61","author":"D Jager","year":"2001","journal-title":"Cancer Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000065472","article-title":"Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression","volume":"63","author":"M Volkmann","year":"2002","journal-title":"Oncology"},{"key":"ref59","first-page":"1963","article-title":"Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients","volume":"27","author":"D Laessig","year":"2007","journal-title":"Anticancer Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1158\/1055-9965.EPI-07-0318","article-title":"Autoantibody approach for serum-based detection of head and neck cancer","volume":"16","author":"HS Lin","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJMoa051931","article-title":"Autoantibody signatures in prostate cancer","volume":"353","author":"X Wang","year":"2005","journal-title":"N Engl J Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1556-0864(15)30352-X","article-title":"Profiling tumor-associated antibodies for early detection of non-small cell lung cancer","volume":"1","author":"L Zhong","year":"2006","journal-title":"J Thorac Oncol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/1354750X.2012.680609","article-title":"Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma","volume":"17","author":"B Zhang","year":"2012","journal-title":"Biomarkers"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T10:48:25Z","timestamp":1563706105000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072458"}},"subtitle":[],"editor":[{"given":"Sophia N.","family":"Karagiannis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,19]]},"references-count":63,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072458","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,19]]}}}